Back to User profile » Dr Thomas W LeBlanc

Paper published by Dr Thomas W LeBlanc:


Oncologist and Patient Preferences for Novel Agents in First-Line Treatment for Chronic Lymphocytic Leukemia: Commonalities and Disconnects

Le H, Ryan K, Wahlstrom SK, Maculaitis MC, Will O, Mulvihill E, LeBlanc TW

Patient Preference and Adherence 2021, 15:99-110

Published Date: 22 January 2021